@abhirajbhal
Terrible experience with Urban Company’s service staff/customer service team today. Unable to find escalation beyond 2 levels, I am posting this. Please suggest the best person to address this. Saving unsavoury details for now. Thanks!
Special Recognition: Women in ICT Award (Public choice) #wtga2022
The winners are:
🥇 Nadini Sahabandu, Sr Manager at @MitraInnovation
🥈 @PriyankaPorwalP , Chief Development Architect at SAP Labs India Pvt. Ltd
🥉 Rita Amuchienwa, Country Account Executive at @intel
⭐️🎊👏
I’m pleased to announce @BCCI’s first step towards tackling discrimination. We are implementing pay equity policy for our contracted @BCCIWomen cricketers. The match fee for both Men and Women Cricketers will be same as we move into a new era of gender equality in 🇮🇳 Cricket.
Read what our MD & CEO Jonathan Hunt has to say about what sets Indian CROs apart. His response has been covered in an industry story published in the c&en magazine recently. To read the complete article, click👉 https://t.co/AuetgM8g6s.
#biopharma#India#CDMO#CRO#USA#Europe
We are delighted to share that our client #Panbela has received an Issue Notification for #patent US 11,098,005 titled “Methods of producing (6S,15S)-3,8,13,18-Tetraazaicosane-6,15-diol” meant for treating #pancreaticcancer.
Read press release👉https://t.co/UMpQZYvMml
#biopharma
Read what our MD & CEO Jonathan Hunt has to say on the shift in clientele with a large number of small & newly founded start-ups from the West partnering with #Syngene to research new treatments & medicines. To read more, click 👉https://t.co/Gxaa7DGZ8b.
#biopharma#india#CDMO
Syngene International (@SyngeneIntl) was started by @Bioconlimited in 1993 to provide research services for pharma companies. Three decades later, the entity wants to become a global science company in its own right, writes @ghoshdj. https://t.co/Qmhc6qPbm5
@kiranshaw
Despite a challenging year, we added 40 new clients & reported revenue growth, excluding export incentives, of 12% to ₹21,802 Mn ($295 Mn) & PAT growth of 4% to ₹3,821 Mn ($52 Mn).
Read full #AnnualReport here👉https://t.co/aRJOR6NNIA.
#Syngene#CDMO#CRO#Biopharma#USA
#TBThursday: In 2015, @SyngeneIntl, @Bioconlimited's research services arm, debuted on the Indian stock market. Syngene’s market capitalization crossed USD 1Bn within a week of listing. To know more about the #BioconLegacy, visit: https://t.co/90N6dbCntE
Our winning formula? Capability to offer integrated services across the #DrugDiscovery, Development, Mfg continuum under one roof; Lean Sigma way of operations; Quality of our work. All this built on the foundation of world-class talent.
#DrugDevelopment#Scientists
5/5
On the range of #scientific work being done at Syngene, our CEO, #Jonathan_Hunt is quoted as saying: “The minute you come into our campus, you can travel the world, scientifically – we do that degree of knowledge-intensive work here”.
#Biopharma#CRO#CDMO#CMO#CRDMO
4/5
Syngene is delighted to share that we are part of Fortune India’s Top 100 Wealth Creators list for 2021.
The criteria involved being a listed company with a 5-year CAGR of 7.5% plus in terms of market cap, revenue &profit (2017-21).
#FortuneIndia#Syngene#FortuneList#CDMO
1/5
Don’t miss the “Chairman To Chairman” Fireside Chat at USAIC’s 15th annual BioPharma Summit (Virtual) #USAIC21. Bob Bradway, Chairman & CEO of Amgen will join @kiranshaw, Executive Chairperson of Biocon in a 1x1 discussion about lessons learned from the i…https://t.co/X2rQcP59D7